Conf-VLKA: A structure-based revisitation of the Virtual Lock-and-key Approach.

In a previous work, we developed the in house Virtual Lock-and-Key Approach (VLKA) in order to evaluate target assignment starting from molecular descriptors calculated on known inhibitors used as an information source. This protocol was able to predict the correct biological target for the whole dataset with a good degree of reliability (80%), and proved experimentally, which was useful for the target fishing of unknown compounds. In this paper, we tried to remodel the previous in house developed VLKA in a more sophisticated one in order to evaluate the influence of 3D conformation of ligands on the accuracy of the prediction. We applied the same previous algorithm of scoring and ranking but, this time, combining it with a structure-based approach as docking. For this reason, we retrieved from the RCSB Protein Data Bank (PDB), the available 3D structures of the biological targets included into the previous work, and we used them to calculate poses of the 7352 dataset compounds in the VLKA biological targets. First, docking protocol has been used to retrieve docking scores, then, from the docked poses of each molecule, 3D-descriptors were calculated (Conf-VLKA), While the use of the simple docking scores proved to be inadequate to improve compounds classification, the Conf-VLKA showed some interesting variations compared to the original VLKA, especially for targets whose ligands present a high number of rotamers. This work represent a first preliminary study to be completed using other techniques such as induced fit docking or molecular dynamics structure clustering to take into account the protein side chains adaptation to ligands structures.

[1]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[2]  M. Dickson,et al.  Key factors in the rising cost of new drug discovery and development , 2004, Nature Reviews Drug Discovery.

[3]  Andreas Bender,et al.  Similarity Searching of Chemical Databases Using Atom Environment Descriptors (MOLPRINT 2D): Evaluation of Performance , 2004, J. Chem. Inf. Model..

[4]  Woody Sherman,et al.  Large-Scale Systematic Analysis of 2D Fingerprint Methods and Parameters to Improve Virtual Screening Enrichments , 2010, J. Chem. Inf. Model..

[5]  M. Levandowsky,et al.  Distance between Sets , 1971, Nature.

[6]  A. M. Almerico,et al.  A3 adenosine receptor: homology modeling and 3D-QSAR studies. , 2013, Journal of molecular graphics & modelling.

[7]  C. Chong,et al.  New uses for old drugs , 2007, Nature.

[8]  M. Tutone,et al.  Multivariate analysis in the identification of biological targets for designed molecular structures: the BIOTA protocol. , 2014, European journal of medicinal chemistry.

[9]  John P. Overington,et al.  Global Analysis of Small Molecule Binding to Related Protein Targets , 2012, PLoS Comput. Biol..

[10]  Sudipto Mukherjee,et al.  Docking Validation Resources: Protein Family and Ligand Flexibility Experiments , 2010, J. Chem. Inf. Model..

[11]  Woody Sherman,et al.  Analysis and comparison of 2D fingerprints: insights into database screening performance using eight fingerprint methods , 2010, J. Cheminformatics.

[12]  M. Tutone,et al.  Studies on a new potential dopaminergic agent: in vitro BBB permeability, in vivo behavioural effects and molecular docking evaluation , 2015, Journal of drug targeting.

[13]  M. L. Jones,et al.  PDBsum: a Web-based database of summaries and analyses of all PDB structures. , 1997, Trends in biochemical sciences.

[14]  J. DiMasi,et al.  Risks in new drug development: Approval success rates for investigational drugs , 2001, Clinical pharmacology and therapeutics.

[15]  Anna Maria Almerico,et al.  Molecular dynamics, dynamic site mapping, and highthroughput virtual screening on leptin and the Ob receptor as anti-obesity target , 2014, Journal of Molecular Modeling.

[16]  Mark McGann,et al.  FRED and HYBRID docking performance on standardized datasets , 2012, Journal of Computer-Aided Molecular Design.

[17]  A. M. Almerico,et al.  Receptor-guided 3D-QSAR approach for the discovery of c-kit tyrosine kinase inhibitors , 2012, Journal of Molecular Modeling.

[18]  A. Lauria,et al.  Lead optimization through VLAK protocol: new annelated pyrrolo-pyrimidine derivatives as antitumor agents. , 2012, European journal of medicinal chemistry.

[19]  Anna Maria Almerico,et al.  Docking and multivariate methods to explore HIV-1 drug-resistance: a comparative analysis , 2008, J. Comput. Aided Mol. Des..

[20]  A. Lauria,et al.  New annelated thieno[2,3-e][1,2,3]triazolo[1,5-a]pyrimidines, with potent anticancer activity, designed through VLAK protocol. , 2013, European journal of medicinal chemistry.

[21]  David E Nichols,et al.  WAY 100635 produces discriminative stimulus effects in rats mediated by dopamine D4 receptor activation , 2009, Behavioural pharmacology.

[22]  Randall T Peterson,et al.  Chemical biology and the limits of reductionism. , 2008, Nature chemical biology.

[23]  M. Tutone,et al.  Phytochemical Indicaxanthin Inhibits Colon Cancer Cell Growth and Affects the DNA Methylation Status by Influencing Epigenetically Modifying Enzyme Expression and Activity , 2015, Lifestyle Genomics.

[24]  Anna Maria Almerico,et al.  IKK-beta inhibitors: an analysis of drug-receptor interaction by using molecular docking and pharmacophore 3D-QSAR approaches. , 2010, Journal of molecular graphics & modelling.

[25]  D. Rogers,et al.  Using Extended-Connectivity Fingerprints with Laplacian-Modified Bayesian Analysis in High-Throughput Screening Follow-Up , 2005, Journal of biomolecular screening.

[26]  M. Tutone,et al.  3D-QSAR pharmacophore modeling and in silico screening of new Bcl-xl inhibitors. , 2010, European journal of medicinal chemistry.

[27]  A. M. Almerico,et al.  Indicaxanthin from Opuntia ficus-indica Crosses the Blood-Brain Barrier and Modulates Neuronal Bioelectric Activity in Rat Hippocampus at Dietary-Consistent Amounts. , 2015, Journal of agricultural and food chemistry.

[28]  Antonio Carrieri,et al.  Recent trends and future prospects in computational GPCR drug discovery: from virtual screening to polypharmacology. , 2013, Current topics in medicinal chemistry.

[29]  A. M. Almerico,et al.  Virtual lock-and-key approach: the in silico revival of Fischer model by means of molecular descriptors. , 2011, European journal of medicinal chemistry.

[30]  Shuxing Zhang,et al.  Polypharmacology: drug discovery for the future , 2013, Expert review of clinical pharmacology.

[31]  Andrew C. Good,et al.  Measuring CAMD technique performance: A virtual screening case study in the design of validation experiments , 2004, J. Comput. Aided Mol. Des..

[32]  Xiang-Qun Xie,et al.  Computational target fishing: what should chemogenomics researchers expect for the future of in silico drug design and discovery? , 2014, Future medicinal chemistry.

[33]  Angelo D. Favia,et al.  Protein promiscuity and its implications for biotechnology , 2009, Nature Biotechnology.

[34]  D. Marona-Lewicka,et al.  Further evidence that the delayed temporal dopaminergic effects of LSD are mediated by a mechanism different than the first temporal phase of action , 2007, Pharmacology Biochemistry and Behavior.

[35]  Anna Maria Almerico,et al.  Molecular dynamics studies on Mdm2 complexes: an analysis of the inhibitor influence. , 2012, Biochemical and biophysical research communications.